About
Our values
Our history
Leads to Development (L2D) is a privately owned organisation formed in 2009 as a high-value service company that supports clients developing innovative therapies. Based in Paris, France, L2D’s international team provides hands-on scientific, regulatory and project management expertise across all stages of drug development.
Historically, L2D’s core expertise centred on CMC and nonclinical aspects of drug development, primarily focused on the earlier stages, from discovery to the first tests in humans. Today, we support our clients throughout their entire development programmes, up to market application, and offer a widened range of services, including clinical trial oversight. Our know-how spans multiple indications and therapeutic product classes, from small molecules to peptides, biologics and implantable medical devices.
The expertise we have built allows our clients to increase the chances of successfully developing their promising new drugs, whilst reducing the time taken to reach their development milestones.
Your specialist team
Morgane CRAUSAZ
Alicja KOSOK
Maya DIA
Jahnavi CHIKIREDDY
Claire DZIENGELEWSKI
Davy BAUDELET
Soundous BELLA BACI
Leila LAREDJ
Davei ATALLA
Marion LANDRY
Joëlle SALAMEH
Vincent DUBOIS
Charlie QUESTEL
Jonathan KEARSEY
Rachael TAITT
Hugh GIFFNEY
Tom MESSIER
Nathalie VALLE
Stephanie DOWELL
